These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25624301)

  • 41. The treatment of noninsulin-dependent diabetes mellitus (NIDDM, type II DM) becomes more and more complex.
    Meinders AE; Lemkes HH
    Neth J Med; 1990 Feb; 36(1-2):39-42. PubMed ID: 2179751
    [No Abstract]   [Full Text] [Related]  

  • 42. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Insulin monotherapy in patients with diabetes mellitus type 2 developing secondary resistance to sulfanilamide preparations].
    Gendeleka GF
    Lik Sprava; 2000 Mar; (2):72-4. PubMed ID: 10862482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Drug treatment of type 2 diabetes].
    Tielmans A; Laloi-Michelin M; Coupaye M; Virally M; Meas T; Guillausseau PJ
    Presse Med; 2007 Feb; 36(2 Pt 2):269-78. PubMed ID: 17258675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacodynamics of second-generation sulfonylureas: dose-effect curve of gliquidone in type II diabetics].
    Procacci V; Giovine A; Roberto MG; Ronchi AM; Lasorsa G; Vendemiale G; Stufano N; Altomare E
    Boll Soc Ital Biol Sper; 1988 Aug; 64(8):731-8. PubMed ID: 3214573
    [No Abstract]   [Full Text] [Related]  

  • 46. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
    Pearson ER; Donnelly LA; Kimber C; Whitley A; Doney AS; McCarthy MI; Hattersley AT; Morris AD; Palmer CN
    Diabetes; 2007 Aug; 56(8):2178-82. PubMed ID: 17519421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Will DPP-4 inhibitors replace sulfonylureas in the treatment of type 2 diabetes? Pro].
    Nauck MA
    Dtsch Med Wochenschr; 2011 Mar; 136(11):546. PubMed ID: 21351041
    [No Abstract]   [Full Text] [Related]  

  • 48. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
    Takamatsu J
    Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus.
    Kabadi MU; Kabadi UM
    Ann Pharmacother; 2003 Nov; 37(11):1572-6. PubMed ID: 14565810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Five ways you can reduce inappropriate prescribing in the elderly: a systematic review.
    Garcia RM
    J Fam Pract; 2006 Apr; 55(4):305-12. PubMed ID: 16608669
    [No Abstract]   [Full Text] [Related]  

  • 51. Appropriate prescribing in asthma. NHS executive promotes prophylaxis.
    Leech P
    BMJ; 1995 Apr; 310(6986):1069-70. PubMed ID: 7677839
    [No Abstract]   [Full Text] [Related]  

  • 52. Japanese Clinical Practice Guideline for Diabetes 2019.
    Araki E; Goto A; Kondo T; Noda M; Noto H; Origasa H; Osawa H; Taguchi A; Tanizawa Y; Tobe K; Yoshioka N
    J Diabetes Investig; 2020 Jul; 11(4):1020-1076. PubMed ID: 33021749
    [No Abstract]   [Full Text] [Related]  

  • 53. [Inappropriate use of sulfonylureas in older adults].
    Pacheco J
    Rev Med Chil; 2016 Nov; 144(11):1497. PubMed ID: 28394970
    [No Abstract]   [Full Text] [Related]  

  • 54. [Reply. Inappropriate use of sulfonylureas in older adults].
    Passi Á
    Rev Med Chil; 2016 Nov; 144(11):1497-1498. PubMed ID: 28394971
    [No Abstract]   [Full Text] [Related]  

  • 55. De-prescribing: When Less Is More in Healthcare.
    Zelmer J
    Healthc Policy; 2016 Feb; 11(3):6-10. PubMed ID: 27027788
    [No Abstract]   [Full Text] [Related]  

  • 56. Nutrition guidelines--a welcome resource.
    Dickey RA
    Endocr Pract; 2003; 9(5):474. PubMed ID: 14609007
    [No Abstract]   [Full Text] [Related]  

  • 57. Time to be cautious about prescribing sulfonylureas?
    Dwyer M
    Br J Gen Pract; 2015 Feb; 65(631):93-4. PubMed ID: 25624301
    [No Abstract]   [Full Text] [Related]  

  • 58. Secondary failure to sulfonylureas in NIDDM. Are sulfonylureas still useful?
    Menon KN; Seshadri MS
    J Assoc Physicians India; 1990 Aug; 38(8):533-4. PubMed ID: 2123182
    [No Abstract]   [Full Text] [Related]  

  • 59. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulfonylureas.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2015 Jan; 65(1):101-4. PubMed ID: 25831689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.